- Home
- BNR vs PEPG Comparison
BNR vs PEPG Comparison
Compare BNR & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- PEPG
- Stock Information
- Founded
- BNR 2014
- PEPG 2018
- Country
- BNR China
- PEPG United States
- Employees
- BNR N/A
- PEPG N/A
- Industry
- BNR Medical Specialities
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- BNR Health Care
- PEPG Health Care
- Exchange
- BNR Nasdaq
- PEPG Nasdaq
- Market Cap
- BNR 38.3M
- PEPG 43.2M
- IPO Year
- BNR 2020
- PEPG 2022
- Fundamental
- Price
- BNR $6.79
- PEPG $1.10
- Analyst Decision
- BNR
- PEPG Buy
- Analyst Count
- BNR 0
- PEPG 3
- Target Price
- BNR N/A
- PEPG $7.67
- AVG Volume (30 Days)
- BNR 58.0K
- PEPG 158.8K
- Earning Date
- BNR 08-21-2025
- PEPG 08-07-2025
- Dividend Yield
- BNR N/A
- PEPG N/A
- EPS Growth
- BNR N/A
- PEPG N/A
- EPS
- BNR N/A
- PEPG N/A
- Revenue
- BNR $72,112,038.00
- PEPG N/A
- Revenue This Year
- BNR $136.32
- PEPG N/A
- Revenue Next Year
- BNR N/A
- PEPG N/A
- P/E Ratio
- BNR N/A
- PEPG N/A
- Revenue Growth
- BNR 0.53
- PEPG N/A
- 52 Week Low
- BNR $2.18
- PEPG $0.88
- 52 Week High
- BNR $9.48
- PEPG $10.15
- Technical
- Relative Strength Index (RSI)
- BNR 58.58
- PEPG 39.02
- Support Level
- BNR $6.03
- PEPG $1.37
- Resistance Level
- BNR $7.80
- PEPG $1.46
- Average True Range (ATR)
- BNR 1.00
- PEPG 0.10
- MACD
- BNR -0.08
- PEPG -0.02
- Stochastic Oscillator
- BNR 32.51
- PEPG 6.90
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.